Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Niacinamide | 2 | 2021 | 2 | 0.870 |
Why?
|
| Macrophages | 2 | 2021 | 15 | 0.860 |
Why?
|
| Energy Metabolism | 2 | 2021 | 13 | 0.850 |
Why?
|
| Autoantibodies | 2 | 2022 | 49 | 0.830 |
Why?
|
| HLA Antigens | 2 | 2022 | 50 | 0.820 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2020 | 4 | 0.820 |
Why?
|
| Tuberculosis | 4 | 2021 | 543 | 0.710 |
Why?
|
| Isoantibodies | 1 | 2020 | 15 | 0.660 |
Why?
|
| Sepsis | 1 | 2021 | 102 | 0.640 |
Why?
|
| Saliva | 7 | 2015 | 22 | 0.540 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2013 | 3 | 0.520 |
Why?
|
| Pregnancy | 4 | 2021 | 1862 | 0.480 |
Why?
|
| Gonadotrophs | 2 | 2013 | 2 | 0.440 |
Why?
|
| HIV-1 | 1 | 2022 | 1260 | 0.420 |
Why?
|
| Repressor Proteins | 1 | 2013 | 7 | 0.420 |
Why?
|
| Apoptosis | 1 | 2013 | 40 | 0.410 |
Why?
|
| Tryptophan | 3 | 2021 | 8 | 0.370 |
Why?
|
| Smoking | 4 | 2015 | 100 | 0.340 |
Why?
|
| Humans | 20 | 2022 | 14537 | 0.340 |
Why?
|
| HIV Infections | 5 | 2022 | 5097 | 0.340 |
Why?
|
| Receptors, GABA | 3 | 2015 | 3 | 0.280 |
Why?
|
| Animals | 4 | 2021 | 1081 | 0.280 |
Why?
|
| Female | 15 | 2021 | 9103 | 0.230 |
Why?
|
| Kynurenine | 2 | 2021 | 7 | 0.210 |
Why?
|
| Oxidative Stress | 3 | 2013 | 19 | 0.200 |
Why?
|
| Case-Control Studies | 3 | 2022 | 480 | 0.200 |
Why?
|
| Mouth Neoplasms | 3 | 2015 | 6 | 0.190 |
Why?
|
| Biological Evolution | 1 | 2021 | 9 | 0.180 |
Why?
|
| Male | 11 | 2021 | 6754 | 0.170 |
Why?
|
| Placental Circulation | 1 | 2020 | 6 | 0.170 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2020 | 18 | 0.170 |
Why?
|
| Immune Tolerance | 1 | 2020 | 22 | 0.170 |
Why?
|
| Catalysis | 1 | 2020 | 6 | 0.170 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2020 | 40 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 150 | 0.160 |
Why?
|
| Epitopes | 1 | 2020 | 97 | 0.160 |
Why?
|
| Lung Neoplasms | 2 | 2010 | 32 | 0.160 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2013 | 9 | 0.150 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2020 | 324 | 0.130 |
Why?
|
| Antioxidants | 3 | 2015 | 26 | 0.130 |
Why?
|
| Adult | 5 | 2020 | 5913 | 0.130 |
Why?
|
| Free Radicals | 1 | 2015 | 6 | 0.120 |
Why?
|
| Infant, Newborn | 1 | 2020 | 1479 | 0.120 |
Why?
|
| Cell Survival | 3 | 2010 | 48 | 0.120 |
Why?
|
| Biomarkers | 4 | 2020 | 327 | 0.120 |
Why?
|
| Infant | 1 | 2020 | 2244 | 0.110 |
Why?
|
| Metalloproteases | 2 | 2013 | 2 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2013 | 2 | 0.110 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2013 | 3 | 0.110 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2013 | 1 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 1 | 0.100 |
Why?
|
| Mice, Knockout | 1 | 2013 | 2 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2013 | 3 | 0.100 |
Why?
|
| Neuropeptides | 1 | 2013 | 2 | 0.100 |
Why?
|
| Testis | 1 | 2013 | 2 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 4 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 4 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 12 | 0.100 |
Why?
|
| Ovary | 1 | 2013 | 5 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2013 | 16 | 0.100 |
Why?
|
| Infertility | 1 | 2013 | 8 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2013 | 79 | 0.100 |
Why?
|
| Epilepsy | 1 | 2013 | 17 | 0.100 |
Why?
|
| Base Sequence | 1 | 2013 | 149 | 0.100 |
Why?
|
| Mice | 1 | 2013 | 135 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2013 | 34 | 0.100 |
Why?
|
| Calmodulin | 1 | 2012 | 1 | 0.100 |
Why?
|
| Salivation | 1 | 2010 | 1 | 0.090 |
Why?
|
| Elective Surgical Procedures | 1 | 2010 | 10 | 0.090 |
Why?
|
| Pleural Effusion | 1 | 2010 | 1 | 0.080 |
Why?
|
| Anticarcinogenic Agents | 1 | 2010 | 1 | 0.080 |
Why?
|
| Penicillamine | 1 | 2010 | 2 | 0.080 |
Why?
|
| Smoke | 1 | 2010 | 2 | 0.080 |
Why?
|
| Arthritis, Juvenile | 1 | 2009 | 1 | 0.080 |
Why?
|
| Tongue Neoplasms | 1 | 2009 | 1 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 25 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 385 | 0.070 |
Why?
|
| Middle Aged | 5 | 2020 | 3601 | 0.070 |
Why?
|
| Aged | 4 | 2010 | 1740 | 0.060 |
Why?
|
| In Vitro Techniques | 2 | 2015 | 54 | 0.050 |
Why?
|
| Protein Binding | 2 | 2015 | 62 | 0.050 |
Why?
|
| Pregnant Women | 1 | 2021 | 89 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2021 | 95 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 59 | 0.040 |
Why?
|
| Comorbidity | 1 | 2021 | 188 | 0.040 |
Why?
|
| Latent Tuberculosis | 1 | 2020 | 45 | 0.040 |
Why?
|
| Cyclin D1 | 2 | 2010 | 2 | 0.040 |
Why?
|
| Ki-67 Antigen | 2 | 2010 | 13 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2019 | 3 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 24 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 217 | 0.040 |
Why?
|
| Gene Expression | 1 | 2019 | 43 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 46 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 32 | 0.040 |
Why?
|
| HIV | 1 | 2021 | 380 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 967 | 0.040 |
Why?
|
| Prevalence | 1 | 2021 | 1192 | 0.030 |
Why?
|
| Risk Factors | 1 | 2021 | 1475 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2021 | 551 | 0.030 |
Why?
|
| Aldehydes | 1 | 2015 | 2 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2015 | 11 | 0.030 |
Why?
|
| Child | 2 | 2013 | 2242 | 0.030 |
Why?
|
| Gonadotropins | 1 | 2012 | 1 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2012 | 1 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 40 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 33 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 77 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 370 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2010 | 1 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 1 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2010 | 2 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2010 | 4 | 0.020 |
Why?
|
| Magnesium | 1 | 2010 | 6 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 6 | 0.020 |
Why?
|
| Albumins | 1 | 2010 | 8 | 0.020 |
Why?
|
| Lactate Dehydrogenases | 1 | 2010 | 4 | 0.020 |
Why?
|
| Uric Acid | 1 | 2010 | 6 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2010 | 3 | 0.020 |
Why?
|
| Calcium | 1 | 2010 | 49 | 0.020 |
Why?
|
| Carcinoma, Large Cell | 1 | 2010 | 1 | 0.020 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2010 | 5 | 0.020 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2010 | 1 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 8 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2010 | 7 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 20 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 10 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2010 | 3 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 21 | 0.020 |
Why?
|
| Oxidants | 1 | 2009 | 6 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 38 | 0.020 |
Why?
|
| Mitochondria | 1 | 2010 | 12 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 71 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 44 | 0.020 |
Why?
|
| DNA Glycosylases | 1 | 2009 | 4 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 50 | 0.020 |
Why?
|
| South Africa | 1 | 2021 | 7596 | 0.020 |
Why?
|
| Pneumonia | 1 | 2010 | 131 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 468 | 0.020 |
Why?
|
| Shock, Hemorrhagic | 1 | 1964 | 1 | 0.010 |
Why?
|
| Shock | 1 | 1964 | 4 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1964 | 13 | 0.010 |
Why?
|
| Resuscitation | 1 | 1964 | 18 | 0.010 |
Why?
|
| Postpartum Period | 1 | 1964 | 85 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1964 | 72 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 2498 | 0.010 |
Why?
|
| Adolescent | 1 | 2009 | 2985 | 0.010 |
Why?
|
| Postpartum Hemorrhage | 1 | 1964 | 75 | 0.010 |
Why?
|
| Sparteine | 1 | 1947 | 1 | 0.000 |
Why?
|
| Sulfates | 1 | 1947 | 7 | 0.000 |
Why?
|
| Work | 1 | 1947 | 9 | 0.000 |
Why?
|
| Labor, Obstetric | 1 | 1947 | 44 | 0.000 |
Why?
|
| Pharmaceutical Preparations | 1 | 1947 | 44 | 0.000 |
Why?
|